AIM
PMC

Acrospire Investment Management’s PharMerica Corporation PMC Stock Holding History

Acrospire Investment Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,883
Closed -$49K – 2014
2017
Q2 		$49K Buy
+1,883
New +$46.3K 0.05% 890

Other funds holding PMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Acrospire Investment Management's PMC Position: Q3 2017 in Review

Acrospire Investment Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 1,883 shares — an estimated $49K sold.

Acrospire Investment Management first reported a position in PMC in Q2 2017 and held it in 1 quarter. The position peaked at $49K in Q2 2017. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Acrospire Investment Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,883 PharMerica Corporation shares in Q3 2017, an estimated $49K.
  • Acrospire Investment Management first reported a position in PharMerica Corporation in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's PharMerica Corporation position peaked at $49K in Q2 2017.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.